Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast Cancer.

Barton VN, Christenson JL, Gordon MA, Greene LI, Rogers TJ, Butterfield K, Babbs B, Spoelstra NS, D'Amato NC, Elias A, Richer JK.

Cancer Res. 2017 Jul 1;77(13):3455-3466. doi: 10.1158/0008-5472.CAN-16-3240. Epub 2017 May 16.


Cooperative Dynamics of AR and ER Activity in Breast Cancer.

D'Amato NC, Gordon MA, Babbs B, Spoelstra NS, Carson Butterfield KT, Torkko KC, Phan VT, Barton VN, Rogers TJ, Sartorius CA, Elias A, Gertz J, Jacobsen BM, Richer JK.

Mol Cancer Res. 2016 Nov;14(11):1054-1067. Epub 2016 Aug 26.


Anti-androgen therapy in triple-negative breast cancer.

Barton VN, Gordon MA, Richer JK, Elias A.

Ther Adv Med Oncol. 2016 Jul;8(4):305-8. doi: 10.1177/1758834016646735. Epub 2016 May 31. No abstract available.


Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.

Barton VN, D'Amato NC, Gordon MA, Christenson JL, Elias A, Richer JK.

Horm Cancer. 2015 Dec;6(5-6):206-13. doi: 10.1007/s12672-015-0232-3. Epub 2015 Jul 23. Review.


Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo.

Barton VN, D'Amato NC, Gordon MA, Lind HT, Spoelstra NS, Babbs BL, Heinz RE, Elias A, Jedlicka P, Jacobsen BM, Richer JK.

Mol Cancer Ther. 2015 Mar;14(3):769-78. doi: 10.1158/1535-7163.MCT-14-0926. Epub 2015 Feb 23.


Insulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma.

Barton VN, Donson AM, Birks DK, Kleinschmidt-DeMasters BK, Handler MH, Foreman NK, Rush SZ.

J Neuropathol Exp Neurol. 2013 May;72(5):442-9. doi: 10.1097/NEN.0b013e31829023dd.


Clinical and molecular characteristics of congenital glioblastoma.

Macy ME, Birks DK, Barton VN, Chan MH, Donson AM, Kleinschmidt-Demasters BK, Bemis LT, Handler MH, Foreman NK.

Neuro Oncol. 2012 Jul;14(7):931-41. doi: 10.1093/neuonc/nos125. Epub 2012 Jun 18.


Memory deficits in patients with pediatric CNS germ cell tumors.

Wilkening GN, Madden JR, Barton VN, Roberts A, Foreman NK.

Pediatr Blood Cancer. 2011 Sep;57(3):486-91. doi: 10.1002/pbc.23096. Epub 2011 May 5.


Survey of MicroRNA expression in pediatric brain tumors.

Birks DK, Barton VN, Donson AM, Handler MH, Vibhakar R, Foreman NK.

Pediatr Blood Cancer. 2011 Feb;56(2):211-6. doi: 10.1002/pbc.22723. Epub 2010 Nov 3.


Aurora kinase A as a rational target for therapy in glioblastoma.

Barton VN, Foreman NK, Donson AM, Birks DK, Handler MH, Vibhakar R.

J Neurosurg Pediatr. 2010 Jul;6(1):98-105. doi: 10.3171/2010.3.PEDS10120.


Immune gene and cell enrichment is associated with a good prognosis in ependymoma.

Donson AM, Birks DK, Barton VN, Wei Q, Kleinschmidt-Demasters BK, Handler MH, Waziri AE, Wang M, Foreman NK.

J Immunol. 2009 Dec 1;183(11):7428-40. doi: 10.4049/jimmunol.0902811. Epub 2009 Nov 16.


Unique molecular characteristics of pediatric myxopapillary ependymoma.

Barton VN, Donson AM, Kleinschmidt-DeMasters BK, Birks DK, Handler MH, Foreman NK.

Brain Pathol. 2010 May;20(3):560-70. doi: 10.1111/j.1750-3639.2009.00333.x. Epub 2009 Sep 10.


PARP1 expression in pediatric central nervous system tumors.

Barton VN, Donson AM, Kleinschmidt-DeMasters BK, Gore L, Liu AK, Foreman NK.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1227-30. doi: 10.1002/pbc.22141.


Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors.

Birks DK, Kleinschmidt-DeMasters BK, Donson AM, Barton VN, McNatt SA, Foreman NK, Handler MH.

Brain Pathol. 2010 Jan;20(1):140-50. doi: 10.1111/j.1750-3639.2008.00255.x. Epub 2009 Feb 9.


Supplemental Content

Loading ...
Support Center